R Squared LTD Bio Atla, Inc. Transaction History
R Squared LTD
- $93.6 Billion
- Q1 2025
A detailed history of R Squared LTD transactions in Bio Atla, Inc. stock. As of the latest transaction made, R Squared LTD holds 11,710 shares of BCAB stock, worth $5,972. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,710
Previous 1,240
844.35%
Holding current value
$5,972
Previous $733,000
454.02%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BCAB
# of Institutions
46Shares Held
13.9MCall Options Held
20.3KPut Options Held
1.2K-
Acorn Capital Advisors, LLC New York, NY4.03MShares$2.06 Million0.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.82MShares$927,1810.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.69MShares$861,9560.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.37MShares$700,7780.03% of portfolio
-
Black Rock Inc. New York, NY792KShares$403,6950.0% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $18.5M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...